Haoxi Health Closes $6.46M Offering at 557% Premium to Market Price, Securing Critical Capital

summarizeSummary

Haoxi Health Technology closed a $6.46 million registered direct offering at a significant premium to its current market price, providing crucial capital despite substantial dilution.

check_boxKey Events

• Offering Closed

  The company closed a registered direct offering on May 12, 2026, raising gross proceeds of $6,455,799.51.

• Premium Pricing

  The offering was priced at $0.25 per share and pre-funded warrant, representing a 557% premium over the current market price of $0.03805.

• Significant Capital Infusion

  The $6.46 million raised is substantial for a company with a market capitalization of approximately $2.4 million, providing critical working capital and general corporate funds.

• Substantial Dilution

  The offering involved the issuance of 9,000,000 Class A ordinary shares and 137,445,353 Class A ordinary shares upon exercise of pre-funded warrants at closing, totaling 146,445,353 new shares. If all pre-funded warrants are exercised, up to 185,034,979 shares could be issued, representing over 300% dilution to existing shareholders.

auto_awesomeAnalysis

Haoxi Health Technology has successfully closed a registered direct offering, raising gross proceeds of $6.46 million. This is a critical capital infusion for the company, which has a market capitalization of only $2.4 million. The offering was priced at $0.25 per share and pre-funded warrant, representing a substantial 557% premium over the current market price of $0.03805. While the offering results in significant dilution, with 146.4 million Class A shares issued at closing (and potentially 185 million if all pre-funded warrants are exercised), the premium pricing indicates strong investor confidence and provides a vital lifeline for the micro-cap company. Directors, officers, and major shareholders have also entered into 90-day lock-up agreements, signaling commitment. This financing follows the termination of an $80 million ATM offering in February and a recent report of a massive net loss, making this capital raise crucial for the company's operational runway. The company also has a clause allowing for a reverse stock split on May 19, 2026, if its stock price remains below $0.10 for three consecutive trading days, which this capital raise may help address.